Drug, Drugs, GlaxoSmithKline, Basel, Alcon, Pharmacology

Le Jan 30, 2019
@swissbusiness a partagé
Switzerland's Novartis sees 2019 drug unit growth as it narrows focus - Reuters https://t.co/c4FrVeOYNH
Open

Novartis 2019 growth outlook leaves investors wanting more

Novartis's 2019 sales and profit growth guidance disappointed investors see...

Le Jan 30, 2019
@swissbusiness a partagé
Switzerland's Novartis sees 2019 drug unit growth as it narrows focus - Reuters https://t.co/c4FrVeOYNH
Open

Novartis 2019 growth outlook leaves investors wanting more

Novartis's 2019 sales and profit growth guidance disappointed investors see...

Novartis 2019 growth outlook leaves investors wanting more

Novartis's 2019 sales and profit growth guidance disappointed investors see...

Novartis to cut 2,550 jobs in Switzerland, UK in profit push

Novartis will cut 2,550 jobs in Switzerland and Britain over four years, it said...

Novartis to cut 2,550 jobs in Switzerland, UK

Novartis to cut 2,550 jobs in Switzerland, UK in profit push ZURICH (Reuters) – Novartis (NOVN.S) will cut 2,550 jobs in Switzerland and Britain over four years, it said on Tuesday, as the ...

GSK plans consumer health spinoff to strengthen focus on pharmaceuticals, vaccines

The British drugmaker plans to separate the consumer health joint venture with Pfizer announced Wednesday three years after the transaction closes.

Novartis to cut 2,550 jobs in Switzerland and England

Novartis will cut 2,550 jobs in Switzerland and Britain over four years, it said, as the Swiss drug maker strives to boost profits and focus on new medicines.

Swiss stocks - Factors to watch on March 5

The Swiss blue-chip SMI was seen opening 0.1 percent lower at 9,384 points on Tu...

Full-stack Pharmaceuticals

The tech industry has quietly started building end-to-end solutions for medical conditions. Big Pharma should be paying attention.

Novartis Eliminating 2,000+ Jobs in U.K., Switzerland

Novartis has announced plans to eliminate more than 2,000 jobs over the next four years—most of those in its headquarters country of Switzerland, the rest in the U.K.—as part of a ...